Search results
Results from the WOW.Com Content Network
In January 2021, Moderna started development of a new form of its vaccine, called mRNA-1273.351, that could be used as a booster shot against the Beta variant (lineage B.1.351). [ 195 ] [ 186 ] In February 2021, Moderna announced that it had manufactured and shipped sufficient amounts of mRNA-1273.351 to the National Institutes of Health to run ...
U.S. regulators on Friday opened up COVID-19 booster shots to all adults, expanding the government’s campaign to shore up protection and get ahead of rising coronavirus cases that may worsen ...
The Food and Drug Administration authorized a fourth dose, or second booster shot, of the Pfizer and Moderna COVID-19 vaccines for adults age 50 and older and immunocompromised groups.
U.S. regulators on Friday shortened the time that people who received Moderna's COVID-19 vaccine have to wait for a booster — to five months rather than six. The two-dose Moderna vaccine is open ...
328 et seq. Specific requirements for over-the-counter (OTC) drugs. The 500 series are regulations for animal feeds and animal medications: 510 et seq. New animal drugs; 556 Tolerances for residues of drugs in food animals; The 600 series covers biological products (e.g. vaccines, blood): 601 Licensing under section 351 of the Public Health ...
In August 2021, the FDA and the CDC authorized the use of an additional mRNA vaccine dose for immunocompromised individuals. [318] [319] The authorization was extended to cover other specific groups in September 2021. [320] [321] [322] In October 2021, the FDA and the CDC authorized the use of either homologous or heterologous vaccine booster ...
The Food and Drug Administration (FDA) recently released guidance saying everyone six months and older is eligible for at least one dose of the updated Covid-19 vaccines; the shots are currently ...
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...